News

Discover how a machine-learning drug toxicity prediction model enhances the predictive power of AI in drug trials, boosting safety.

Ongoing peanut patch treatment helps toddlers develop lasting tolerance while remaining safe, offering hope for families managing peanut allergies.

Study identifies which patients benefit most from new schizophrenia drug. It analyzed electronic medical records from 49 patients hospitalized for schizophrenia, schizoaffective disorder, or bipolar disorder with psychotic features.

Researchers showed that a protein language model could design functional human antibodies that recognized unique antigen sequences of specific viruses, without requiring part of the antibody sequence as a starting template.

New research has identified a molecular cascade that causes synaptic dysfunction that is shared by Alzheimer's and Parkinson's.

Scientists have visualized for the first time how opioids such as loperamide and the antidote naloxone engage a key brain receptor, offering insight that could lead to better pain treatments.

Researchers found that adolescents treated with the antibiotic doxycycline were ~30% less likely to develop schizophrenia as adults. The findings suggest that targeting brain inflammation could help reduce the future risk of severe mental illness.

By delivering an immune-stimulating molecule alongside immunotherapy, nanoparticles help the immune system attack ovarian tumors.

Researchers found that intermittent fasting, when calorie intake remains unchanged, does not improve insulin sensitivity or other metabolic measures. Time-restricted eating shifted participants’ circadian rhythms.

New compound fragment disables cancer cells’ antioxidant defenses, paving the way for a next-generation treatment strategy that could work across multiple tumor types.